PaxMedica Inc

NASDAQ:PXMD  
3.38
+0.28 (+9.03%)
7:59:33 PM EDT: $3.13 -0.25 (-7.40%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

PaxMedica Inc Stock, NASDAQ:PXMD

303 South Broadway, Suite 125, Tarrytown, New York 10591
United States of America
Phone: +1.914.987.2876
Number of Employees: 2

Description

PaxMedica, Inc. is an early clinical stage biopharmaceutical company. It focuses on the development of anti-purinergic therapies for the treatment of neurodevelopmental disorders, including autism spectrum disorder and Fragile X syndrome tremor-ataxia. The company was founded in April 5, 2018 and is headquartered in Woodcliff Lake, NJ.